Abstract
Attention-based decoder models were used to generate libraries of novel inhibitors for the HMG-Coenzyme A reductase (HMGCR) enzyme. These deep neural network models were pretrained on previously synthesized drug-like molecules from the ZINC15 database to learn the syntax of SMILES strings and then fine-tuned with a set of ∼1000 molecules that inhibit HMGCR. The number of layers used for pretraining and fine-tuning was varied to find the optimal balance for robust library generation. Virtual screening libraries were also generated with different temperatures and numbers of input tokens (prompt length) to find the most desirable molecular properties. The resulting libraries were screened against several criteria, including IC50 values predicted by a dense neural network (DNN) trained on experimental HMGCR IC50 values, docking scores from AutoDock Vina (via Dockstring), a calculated quantitative estimate of druglikeness, and Tanimoto similarity to known HMGCR inhibitors. It was found that 50/50 or 25/75% pretrained/fine-tuned models with a nonzero temperature and shorter prompt lengths produced the most robust libraries, and the DNN-predicted IC50 values had good correlation with docking scores and statin similarity. 42% of generated molecules were classified as statin-like by k-means clustering, with the rosuvastatin-like group having the lowest IC50 values and lowest docking scores.